Evoke Pharma Inc. buy DomRuinart
Start price
18.11.20
/
50%
€32.66
Target price
18.11.21
€60.00
Performance (%)
-3.60%
End price
30.11.20
€31.49
Summary
This prediction ended on 30.11.20 with a price of €31.49. With a performance of -3.60%, the BUY prediction by DomRuinart finished with a loss. DomRuinart has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Evoke Pharma Inc. | - | - | - | - |
iShares Core DAX® | -0.372% | 5.236% | 16.908% | 16.016% |
iShares Nasdaq 100 | -1.950% | 1.680% | 19.890% | 31.832% |
iShares Nikkei 225® | -1.690% | 7.286% | 12.202% | 3.400% |
iShares S&P 500 | -0.399% | 2.379% | 20.975% | 36.224% |
According to DomRuinart what are the pros and cons of Evoke Pharma Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by DomRuinart for this prediction
In the thread Evoke Pharma Inc. diskutieren
Buy mit Kursziel 5,0
In the thread Trading Evoke Pharma Inc.
Buy beendet